Cochlear Ltd has released a press release.
COH - Profile Plus FDA Approval
Filed with ASX ·
Watch Cochlear's latest callCochlear (ASX:COH) Q4 2026 Earnings Call · Replay · Aug 17Read the transcript of Cochlear (ASX:COH) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Cochlear
- Cochlear announces launch of Nucleus Profile Plus implant
- COH Half Year Results Analyst - 19.02.2019
- COH Half Year Results Media Release - 19.02.2019
- COH - Ruling in USA Patent Infringement Case
- 2018 Chairmans AGM Address to Shareholders
Later from Cochlear
- FY19 Results ASX & Media Release
- 2019 Chairmans AGM Address to Shareholders
- Cochlear reduces earnings guidance due to coronavirus
- HY20 Result ASX & Media Release
- HY20 Result Presentation Slides
Follow Cochlear into a list and get an email when it puts out news.
Follow Cochlear